Press Releases

Press Releases

Press Release | 06.12.26
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496

Read more >

Press Release | 06.11.26
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded

Read more >

Press Release | 05.14.26
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
 -- Zola ® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia’s history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the

Read more >

Press Release | 03.26.26
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
-- Zola ® revenues increase 17% year-over-year -- -- Arcadia and Roosevelt Resources terminate proposed business combination -- -- Exercise of preferred investment options yields $2.1 million gross proceeds -- DALLAS, March 26, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.

Read more >

Press Release | 01.12.26
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
DALLAS , Jan. 12, 2026 (GLOBE NEWSWIRE) --  Arcadia Biosciences, Inc . ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive agreements for the immediate exercise of certain outstanding preferred investment options to purchase

Read more >

Press Release | 12.26.25
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
DALLAS , Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc . ® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025 , it received a notice from Roosevelt Resources, LP , terminating the Securities Exchange Agreement between

Read more >

Press Release | 11.07.25
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
-- Zola ® year-to-date revenues increase 26% year over year -- -- Arcadia gross profit margins exceed 30% for 11 th straight quarter -- -- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS , Nov. 07, 2025 (GLOBE NEWSWIRE) --   Arcadia Biosciences, Inc .

Read more >

Press Release | 08.14.25
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
-- Arcadia revenues increase 11% year over year driven by 24% growth in Zola ® -- -- Arcadia receives 2.7 million shares of stock in ABVE -- -- Arcadia eliminates $1M in liabilities -- DALLAS , Aug. 14, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.

Read more >

Press Release | 05.08.25
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
-- Revenues increase 22% year over year driven by 90% growth in Zola ® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS , May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences,

Read more >

Press Release | 04.29.25
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
DALLAS , April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025 .

Read more >